(-0.08%) 5 143.00 points
(-0.06%) 38 534 points
(0.02%) 17 908 points
(-0.29%) $82.39
(1.53%) $2.06
(-1.08%) $2 332.30
(-2.21%) $27.05
(-0.62%) $955.50
(0.19%) $0.934
(0.36%) $11.02
(0.24%) $0.798
(-0.24%) $93.08
Live Chart Being Loaded With Signals
Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of oncology, cardiovascular system, renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses...
Stats | |
---|---|
आज की मात्रा | 2.20M |
औसत मात्रा | 1.11M |
बाजार मूल्य | 3 658.79B |
EPS | ¥0 ( 2024-04-29 ) |
अगली कमाई की तारीख | ( ¥122.99 ) 2024-05-09 |
Last Dividend | ¥50.00 ( 2023-06-29 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 30.07 |
ATR14 | ¥12.75 (0.19%) |
मात्रा सहसंबंध
Otsuka Holdings Co., Ltd. सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध |
---|
10 सबसे अधिक नकारात्मक सहसंबंध |
---|
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Otsuka Holdings Co., Ltd. सहसंबंध - मुद्रा/वस्त्र
Otsuka Holdings Co., Ltd. वित्तीय
Annual | 2023 |
राजस्व: | ¥2 018.57B |
सकल लाभ: | ¥1 407.35B (69.72 %) |
EPS: | ¥224.11 |
FY | 2023 |
राजस्व: | ¥2 018.57B |
सकल लाभ: | ¥1 407.35B (69.72 %) |
EPS: | ¥224.11 |
FY | 2022 |
राजस्व: | ¥1 738.00B |
सकल लाभ: | ¥1 168.50B (67.23 %) |
EPS: | ¥246.81 |
FY | 2021 |
राजस्व: | ¥1 498.28B |
सकल लाभ: | ¥1 003.25B (66.96 %) |
EPS: | ¥231.35 |
Financial Reports:
No articles found.
Otsuka Holdings Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥50.00 (N/A) |
¥0 (N/A) |
¥50.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥28.00 | 2011-03-29 |
Last Dividend | ¥50.00 | 2023-06-29 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 27 | -- |
Total Paid Out | ¥1 121.00 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.85 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.03 | |
Div. Directional Score | 8.61 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8058.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7315.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6564.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
5915.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
4578.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
3834.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3085.T | Ex Dividend Knight | 2023-06-29 | Semi-Annually | 0 | 0.00% | |
1951.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
9507.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
8395.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0602 | 1.500 | 8.80 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0362 | 1.200 | 8.79 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0508 | 1.500 | -0.547 | -0.821 | [0.1 - 1] |
payoutRatioTTM | 0.458 | -1.000 | 5.42 | -5.42 | [0 - 1] |
currentRatioTTM | 1.989 | 0.800 | 5.06 | 4.05 | [1 - 3] |
quickRatioTTM | 1.533 | 0.800 | 5.69 | 4.55 | [0.8 - 2.5] |
cashRatioTTM | 0.769 | 1.500 | 6.84 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0468 | -1.500 | 9.22 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 37.62 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 521.91 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 310.60 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0658 | -1.500 | 9.74 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.697 | 1.000 | 1.713 | 1.713 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.126 | 1.000 | 9.49 | 9.49 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.799 | 1.000 | 1.119 | 1.119 | [0.2 - 2] |
assetTurnoverTTM | 0.601 | 0.800 | 9.33 | 7.46 | [0.5 - 2] |
Total Score | 11.20 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 28.43 | 1.000 | 7.23 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0508 | 2.50 | -0.352 | -0.821 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 310.60 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.727 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 521.91 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.458 | 1.500 | 5.42 | -5.42 | [0 - 1] |
pegRatioTTM | 1.320 | 1.500 | 4.53 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.140 | 1.000 | 8.99 | 0 | [0.1 - 0.5] |
Total Score | 6.03 |
Otsuka Holdings Co., Ltd.
Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of oncology, cardiovascular system, renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides EQUELLE, a product for women's health and beauty; BODYMAINTÉ Jelly, a conditioning food product; BODYMAINTÉ Drink, a drinkable-liquid; POCARI SWEAT, a drink; Calorie Mate, a nutritional food; OS-1, an oral rehydration solution; HINEX-R, a concentrated liquid diet; and Oronine H Ointment, a household antiseptic medicine. In addition, the company offers soft drinks, food products, and wines; chemicals; clinical testing and medical equipment; cosmetics; warehousing and transport services; analysis and measurement equipment; pharmaceutical intermediates; vehicle headlight testers; synthetic resin molded products; paper products; artificial turf; ceramic boards, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; stable isotopes; software and services to enhance management of mental healthcare systems; potassium titanate; polyolefin foams; spring and mineral water; industrial chemicals; hydrazine; insecticide and toiletry products; and adhesive tapes. Further, it operates a hotel. Otsuka Holdings Co., Ltd. was founded in 1921 and is based in Tokyo, Japan.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं